Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Uniqure
Uniqure
(QURE)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Glybera
Alipogene tiparvovec
2012-10-25
Hyperlipoproteinemia type i
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Alipogene tiparvovec
hyperlipoproteinemia type i
,
hyperlipidemias
,
hyperlipoproteinemias
Mycophenolate sodium
hyperlipoproteinemia type i
Mycophenolic acid
hyperlipoproteinemia type i
Orgotein
amyotrophic lateral sclerosis
,
motor neuron disease
,
sclerosis
Alfacalcidol
hiv infections
,
hepatitis c
,
chronic hepatitis c
,
hepatitis
,
hepatitis a
,
drug-related side effects and adverse reactions
,
melanoma
Lotamilast
parkinson disease
,
central nervous system diseases
,
brain diseases
,
nervous system diseases
,
movement disorders
,
neurodegenerative diseases
,
dyskinesias
,
melanoma
,
colorectal neoplasms
,
neoplasms
,
non-small-cell lung carcinoma
,
head and neck neoplasms
,
esophageal neoplasms
,
glioblastoma
,
astrocytoma
Remetinostat
parkinson disease
,
central nervous system diseases
,
brain diseases
,
nervous system diseases
,
movement disorders
,
neurodegenerative diseases
,
dyskinesias
,
melanoma
,
colorectal neoplasms
,
neoplasms
,
non-small-cell lung carcinoma
,
head and neck neoplasms
,
esophageal neoplasms
,
glioblastoma
,
astrocytoma
Usistapide
recurrence
,
non-hodgkin lymphoma
,
b-cell lymphoma marginal zone
,
follicular lymphoma
,
b-cell lymphoma
,
hearing loss
,
sensorineural hearing loss
,
deafness
,
lymphoma
Solumedrol
hyperlipoproteinemia type i
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use